Microplastics, tiny plastic particles less than 5 mm in size, have become ubiquitous in our environment. These particles are found in our oceans, soil, air, and even in our food and drinking water. The widespread presence of microplastics has raised concerns about their potential impact on human health, particularly in relation to cardiovascular disease and respiratory conditions.
The New England Journal of Medicine (NEJM) has recently published groundbreaking research on the effects of microplastics on human health. These studies provide compelling evidence that exposure to microplastics may contribute to the development of cardiovascular disease and other health problems.
Background on Microplastics
Microplastics are derived from the breakdown of larger plastic items, such as plastic bags, bottles, and synthetic clothing fibers. They can also be intentionally manufactured for use in personal care products, such as exfoliating beads in facial scrubs. Once released into the environment, microplastics can persist for hundreds of years, accumulating in ecosystems and entering the food chain[1].
Humans can be exposed to microplastics through various routes, including ingestion of contaminated food and water, inhalation of airborne particles, and skin contact with contaminated products. The small size of microplastics allows them to cross biological barriers and enter the bloodstream, where they can potentially cause inflammation and oxidative stress[1].
Microplastics and Nanoplastics in Atheromas and Cardiovascular Disease
In a prospective, multicenter study published in the NEJM, researchers investigated the presence of microplastics and nanoplastics (MNPs) in carotid artery plaques and their association with cardiovascular disease[3]. The study involved 304 patients undergoing carotid endarterectomy for asymptomatic carotid artery disease.
The researchers found that polyethylene, a common type of plastic, was detected in the carotid artery plaques of 58.4% of patients, with an average level of 21.7 μg per milligram of plaque. Additionally, 12.1% of patients had measurable amounts of polyvinyl chloride in their plaques[3].
Electron microscopy revealed visible, jagged-edged foreign particles among plaque macrophages and scattered in the external debris. Radiographic examination showed that some of these particles included chlorine[3].
Notably, patients with MNPs detected within their atheromas were at a significantly higher risk for myocardial infarction, stroke, or death from any cause compared to those without detectable MNPs (hazard ratio, 4.53; 95% confidence interval, 2.00 to 10.27; P<0.001)[3].
This study provides the first direct evidence that exposure to MNPs may contribute to the development of cardiovascular disease in humans. The findings suggest that MNPs may promote inflammation and oxidative stress within atherosclerotic plaques, leading to plaque instability and increased risk of cardiovascular events.
Plastic Bronchitis
In a separate case report published in the NEJM, researchers described a rare condition called plastic bronchitis in a patient who had undergone surgical repair of the heart[4]. Plastic bronchitis is characterized by the formation of large, branching casts within the airways, which can cause severe respiratory distress.
The patient in this case report had a history of congenital heart disease and had undergone multiple surgical procedures. He presented with cough and shortness of breath, and imaging studies revealed the presence of branching casts within his airways[4].
The casts were removed via bronchoscopy, and analysis revealed that they were composed of fibrin and inflammatory cells, with embedded microplastic particles. The source of the microplastics was unclear, but the authors speculated that they may have originated from the patient’s surgical procedures or from environmental exposure[4].
This case highlights the potential for microplastics to contribute to respiratory conditions, particularly in vulnerable populations such as those with congenital heart disease. Further research is needed to understand the mechanisms by which microplastics may promote airway inflammation and cast formation.
Conclusion
The studies published in the NEJM provide compelling evidence that exposure to microplastics and nanoplastics may have significant impacts on human health. The presence of these particles in atherosclerotic plaques and their association with increased risk of cardiovascular events is particularly concerning, given the widespread exposure to microplastics in the environment.
Additionally, the case report of plastic bronchitis highlights the potential for microplastics to contribute to respiratory conditions, particularly in vulnerable populations. As the use of plastics continues to increase globally, it is crucial that we take steps to reduce our exposure to microplastics and to mitigate their impact on human health and the environment.
Further research is needed to fully understand the mechanisms by which microplastics affect human health and to develop strategies for reducing exposure and mitigating their effects. In the meantime, individuals can take steps to reduce their exposure by avoiding products containing microbeads, properly disposing of plastic waste, and supporting policies aimed at reducing plastic pollution.
References
[1] Microplastics: A Real Global Threat for Environment and Food Safety. NCBI. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920460/
[2] Introduction – Microplastics – ITRC. https://mp-1.itrcweb.org/introduction/
[3] Microplastics and Nanoplastics in Atheromas and Cardiovascular Disease. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2309822
[4] Plastic Bronchitis. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMicm2111951